Appendix E: supporting documents

Appendix E: supporting documents

Supporting documents are available online. These include the following:

  • Evidence reviews:

    • Review 1: 'Prevention of cardiovascular disease at population level (Question 1; phase 1)'

    • Review 2: 'Prevention of cardiovascular disease at population level (Question 1; phase 2)'

    • Review 3: 'Prevention of cardiovascular disease at population level (Question 1; phase 3)'

    • Review 4: 'Barriers to, and facilitators for, multiple risk factor programmes aimed at reducing cardiovascular disease within a given population: a systematic review of qualitative research'.

  • Primary research:

    • Review 5: 'Population and community programmes addressing multiple risk factors to prevent cardiovascular disease: A qualitative study into how and why some programmes are more successful than others'.

  • Economic analysis:

    • Review 6: 'Prevention of cardiovascular disease at population level (Question 1; cost-effectiveness)'

    • 'Prevention of cardiovascular disease at population level: modelling strategies for primary prevention of cardiovascular disease'.

  • Expert reports:

    • Report 1: 'The effectiveness of physical activity promotion interventions'

    • Report 2: 'Health policy analysis'

    • Report 3: 'Expert testimony on salt and cardiovascular disease'

    • Report 4: 'The relationship between commercial interests and risk of cardiovascular disease'

    • Report 5: 'Regional development of a population-based collaborative CVD prevention strategy: the experience of NHS West Midlands'

    • Report 6: 'NICE guidance on the prevention of CVD at population level: evidence from the Co-operative Group'

    • Report 7: 'Population and community programmes addressing multiple risk factors to prevent cardiovascular disease (CVD): addendum to qualitative study produced by Peninsula Technology Assessment Group for NICE: CVD programme – Heart of Mersey (HoM)'

    • Report 8: 'Expert testimony paper on the independent evaluation of "have a heart Paisley" phase one (Scotland's national CHD prevention demonstration project)'

    • Report 9: 'Expert testimony on the public health harm caused by industrially produced trans fatty acids and actions to reduce and eliminate them from the food system in the UK'

    • Report 10: 'Prevention of cardiovascular disease at a population level: evidence on interventions to address dietary fats'

    • Report 11: 'CVD risk factors: paradigms and pathways'

    • Report 12: 'CVD prevention in populations: lessons from other countries'

    • Report 13: 'Will CVD prevention widen health inequalities?'

    • Report 14: 'Food manufacturer's perspective'.

  • Fieldwork report: 'Fieldwork on prevention of cardiovascular disease at population level'.

  • A quick reference guide for professionals whose remit includes public health and for interested members of the public.

For information on how NICE public health guidance is developed see:

  • National Institute for Health and Care Excellence (NICE)